跳至主要内容
临床试验/NCT02314702
NCT02314702进行中(未招募)不适用

Post Market Clinical Follow-Up Study Protocol for PROFEMUR® L Revision Femoral Stems

MicroPort Orthopedics Inc.1 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2015年9月4日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
26
试验地点
1
主要终点
Number of participants who require a revision

研究概览

简要总结

MicroPort Orthopedics (MPO) is conducting this PMCF study to evaluate the safety and efficacy of its THA and resurfacing components marketed in the EU. These types of studies are required by regulatory authorities for all THA and resurfacing devices that do not have medium to long-term clinical evidence available at the time of gaining approval to market in the EU. This study has been designed in accordance with MEDDEV 2.12/2 rev 2.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Has undergone revision total hip arthroplasty
  • Subject is implanted with the specified combination of components
  • Subject is willing and able to complete required study visits or assessments

排除标准

  • Subjects currently enrolled in another clinical study
  • Subjects unwilling to sign the Informed Consent document
  • Subjects with substance abuse issues
  • Subjects who are incarcerated or have pending incarceration

结局指标

主要结局

Number of participants who require a revision

时间窗: 10 years post-operative

The primary objective of this study is to estimate the revision rate of all components at specified intervals out to 10 years follow-up.

次要结局

  • Patient functional score on the the Oxford Hip Score instrument(Screening (First Available), 2-5 years, 5-7 years, and 10 years)
  • Patient functional score on the EQ-5D-3L instrument(Screening (First Available), 2-5 years, 5-7 years, and 10 years)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验